Interim Condensed Consolidated Statements of Income (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Revenues:
Net patient revenues	$ 214,433,000	$ 205,632,000	$ 426,494,000	$ 405,401,000
Other revenues	10,469,000	10,923,000	20,815,000	21,685,000
Net operating revenues	224,902,000	216,555,000	447,309,000	427,086,000
Cost and Expenses:
Salaries, wages and benefits	131,914,000	125,614,000	257,630,000	245,339,000
Other operating	57,467,000	55,696,000	117,214,000	111,438,000
Facility rent	9,981,000	9,913,000	19,966,000	19,799,000
Depreciation and amortization	9,236,000	8,605,000	18,169,000	16,505,000
Interest	598,000	644,000	1,188,000	934,000
Total costs and expenses	209,196,000	200,472,000	414,167,000	394,015,000
Income Before Non–Operating Income	15,706,000	16,083,000	33,142,000	33,071,000
Non–Operating Income	4,130,000	4,281,000	8,352,000	8,853,000
Income Before Income Taxes	19,836,000	20,364,000	41,494,000	41,924,000
Income Tax Provision	(7,478,000)	(7,853,000)	(15,894,000)	(16,184,000)
Net Income	12,358,000	12,511,000	25,600,000	25,740,000
Dividends to Preferred Stockholders	(2,167,000)	(2,167,000)	(4,335,000)	(4,335,000)
Net Income Available to Common Stockholders	$ 10,191,000	$ 10,344,000	$ 21,265,000	$ 21,405,000
Earnings Per Common Share:
Basic (in Dollars per share)	$ 0.74	$ 0.75	$ 1.54	$ 1.54
Diluted (in Dollars per share)	$ 0.71	$ 0.72	$ 1.48	$ 1.50
Weighted Average Common Shares Outstanding:
Basic (in Shares)	13,772,873	13,868,470	13,767,248	13,855,900
Diluted (in Shares)	14,381,746	14,282,785	14,336,027	14,226,887
Dividends Declared Per Common Share (in Dollars per share)	$ 0.40	$ 0.34	$ 0.74	$ 0.66